Bayer AGBayer AG will recover after ending in a last wave 5 of C. On the right side mentioned all the former gaps.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−19.65 MXN
−55.14 B MXN
893.06 B MXN
982.40 M
About BAYER AG NA O.N.
Sector
CEO
William N. Anderson
Headquarters
Leverkusen
Website
Founded
1952
ISIN
DE000BAY0017
FIGI
BBG005PTPF97
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
BAYER AG: $40.60 | Aspirin AlkaSeltzer Monsanto + $11bn Settled Bill Anderson doing the roadshow in Dc and Carlyle Group seems to be
going in heavy at current levels or lower for the next RUN UP
a long game to make a killing for heavy hitters in the pharma bio agri chemical business
the timing to position for such a deal takes time and feel in the this type of
Bayer (BAYN): End of a long 9-year correctionBayer (BAYN): XETR:BAYN
Upon request from one of our members, we're taking a closer look at Bayer AG. We believe that we are still in an overarching Wave II. This wave finds its last true support at the 88.2% retracement level at €24.51. Falling significantly below this level would likely lead
Bayer (BAYN): Is the Bottom Finally Here?Since our initial analysis in November, Bayer's stock has experienced a 40% pullback. Despite missing our limit order by 2%, we have decided to enter the market now and plan to make additional purchases if the price drops further.
The stock has held around the 88.2% Fibonacci retracement level. We
GERMANY STOCK > ( BAYN ) long Based on my graphic analysis I observe a bullish projection of 11% in the price of this corporation, that is; from $28.79 it will rise to $31.96. With a sell exit emerging at $26.47, it is worth remembering that exactly how long the rally will take is unpredictable, the market will simply do its job
Bayer double bottom Bayer was trending down for last almost a year. Now it's seems to draw the double botton. Stock found the support, bounce twice and seems to be recovering. Moreover, the dividend is incomingin near future what could boost the price additionally.
this is not a recomendation, only my guess what could
If Germany is the sick man of Europe. #Bayer looking deathlyThe #EU is Marxist, Socialist, and is involved in Price setting
That didn't work out too well for USSR as economic powerhouse
and so too we see the once great German economy being brought to it's knees.
It is being de-industralized and being brought down in a great economic levelling of the union
Bayer Cuts Dividends to Reduce DebtIn a strategic move to tackle its mounting debt and enhance financial flexibility, Bayer ( OTC:BAYRY ), the German pharmaceutical giant, has announced a significant shift in its dividend policy. The decision, though met with mixed reactions from investors and analysts, underscores the company's comm
Buy Bayer AG Scalp and HOLDHello, here my IDEA for BAYER AG, a big player in Germany
and WORLDWIDE. Make 3 Position and take the Profits, for Longtime
Investors BUY and HOLD.
BAYN: Potential BuyRetesting the channel price recently broke out of, this represents a possible buy opportunity backed with a recent insider buying activity. First target right after the gap where you could take partials, then 48 EUR. If you believe in the company why not hold to ATH.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
B
BAYZ4685470
Bayer US Finance II LLC 3.95% 15-APR-2045Yield to maturity
7.50%
Maturity date
Apr 15, 2045
Explore more bonds
Curated watchlists where BAYN/N is featured.
Frequently Asked Questions
The current price of BAYN/N is 570.00 MXN — it hasn't changed in the past 24 hours. Watch BAYER AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange BAYER AG stocks are traded under the ticker BAYN/N.
We've gathered analysts' opinions on BAYER AG future price: according to them, BAYN/N price has a max estimate of 791.28 MXN and a min estimate of 470.49 MXN. Watch BAYN/N chart and read a more detailed BAYER AG stock forecast: see what analysts think of BAYER AG and suggest that you do with its stocks.
BAYN/N reached its all-time high on Oct 16, 2017 with the price of 2,627.12 MXN, and its all-time low was 500.00 MXN and was reached on Jul 10, 2024. View more price dynamics on BAYN/N chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BAYN/N stock is 0.00% volatile and has beta coefficient of 0.63. Track BAYER AG stock price on the chart and check out the list of the most volatile stocks — is BAYER AG there?
Today BAYER AG has the market capitalization of 410.62 B, it has decreased by −5.17% over the last week.
Yes, you can track BAYER AG financials in yearly and quarterly reports right on TradingView.
BAYER AG is going to release the next earnings report on Mar 5, 2025. Keep track of upcoming events with our Earnings Calendar.
BAYN/N earnings for the last quarter are 5.27 MXN per share, whereas the estimation was 6.90 MXN resulting in a −23.67% surprise. The estimated earnings for the next quarter are 21.00 MXN per share. See more details about BAYER AG earnings.
BAYER AG revenue for the last quarter amounts to 218.68 B MXN, despite the estimated figure of 225.23 B MXN. In the next quarter, revenue is expected to reach 240.90 B MXN.
BAYN/N net income for the last quarter is −91.77 B MXN, while the quarter before that showed −667.98 M MXN of net income which accounts for −13.64 K% change. Track more BAYER AG financial stats to get the full picture.
Yes, BAYN/N dividends are paid annually. The last dividend per share was 2.01 MXN. As of today, Dividend Yield (TTM)% is 0.56%. Tracking BAYER AG dividends might help you take more informed decisions.
As of Nov 21, 2024, the company has 99.72 K employees. See our rating of the largest employees — is BAYER AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. BAYER AG EBITDA is 243.76 B MXN, and current EBITDA margin is 25.91%. See more stats in BAYER AG financial statements.
Like other stocks, BAYN/N shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BAYER AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BAYER AG technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BAYER AG stock shows the sell signal. See more of BAYER AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.